Neogen Corporation

Neogen Corporation

NEOG·NASDAQ

$8.81

-1.2%
HealthcareMedical - Diagnostics & Research

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

At a Glance

Live Snapshot
Market Cap$1.92B
EPS-5.0300
P/E Ratio-1.75
Earnings Date07/28/2026

neog

Other Non-Current Liabilities

Last Annual Value

29.99M

3-Year CAGR

41%

5-Year CAGR

41%

10-Year CAGR

31%

Neogen Corporation

Neogen Corporation Competitors Analysis of Other Non-Current Liabilities

NEOG · NASDAQ
CompanyOther Non-Current Liabilities
CAGR 3Y
CAGR 5Y
CAGR 10Y
29.99M
3.5%47.5%28.6% 
NVCR logo
NovoCure Limited
NASDAQ:NVCR
-37.71M
N/AN/AN/A
0.00
N/AN/AN/A
8.24M
-56.8%87.0%N/A
171.00K
-70.3%-49.0%-13.0%
AZTA logo
Azenta, Inc.
NASDAQ:AZTA
-28.61M
N/AN/AN/A
-19.67M
N/AN/AN/A
63.85M
-16.9%8.2%9.0%
0.00
N/AN/AN/A
0.00
N/AN/AN/A
Neogen Corporation

Neogen Corporation Fair Value Envelope

NEOG · NASDAQ

Our analysis suggests that NEOG has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $8.81, this represents a potential HIDDEN relative to our calculated worth for Neogen Corporation.

Intrinsic Value
Current Price: $8.81